Orbimed Advisors LLC Crinetics Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

$3.69 Billion
Q4 2024

A detailed history of Orbimed Advisors LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 999,000 shares of CRNX stock, worth $37.4 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

999,000

Previous 1,050,055 4.86%

Holding current value

$37.4 Million

Previous $53.6 Million 4.77%

% of portfolio

1.38%

Previous 1.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$50.66 - $60.69 $2.59 Million - $3.1 Million	-51,055 Reduced 4.86%	999,000 $51.1 Million
Q3 2024 Nov 14, 2024	SELL	$43.83 - $54.98 $10.1 Million - $12.7 Million	-230,745 Reduced 18.02%	1,050,055 $53.6 Million
Q2 2024 Aug 14, 2024	SELL	$42.12 - $51.91 $4.39 Million - $5.41 Million	-104,200 Reduced 7.52%	1,280,800 $57.4 Million
Q1 2024 May 15, 2024	SELL	$34.76 - $46.81 $9.81 Million - $13.2 Million	-282,360 Reduced 16.93%	1,385,000 $64.8 Million
Q4 2023 Feb 14, 2024	SELL	$25.62 - $37.07 $31.5 Million - $45.5 Million	-1,228,714 Reduced 42.43%	1,667,360 $59.3 Million
Q3 2023 Nov 14, 2023	SELL	$15.97 - $30.59 $16.8 Million - $32.3 Million	-1,054,722 Reduced 26.7%	2,896,074 $86.1 Million
Q1 2023 May 15, 2023	BUY	$15.31 - $21.1 $11.5 Million - $15.9 Million	753,920 Added 23.58%	3,950,796 $63.4 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $3.87 Million - $5.68 Million	200,000 Added 6.67%	3,196,876 $90.8 Million
Q2 2021 Aug 16, 2021	BUY	$15.9 - $21.15 $3.87 Million - $5.15 Million	243,309 Added 8.84%	2,996,876 $56.5 Million
Q2 2020 Aug 14, 2020	BUY	$13.04 - $23.23 $9.31 Million - $16.6 Million	714,285 Added 35.03%	2,753,567 $48.2 Million
Q2 2019 Aug 14, 2019	BUY	$21.48 - $27.71 $2.69 Million - $3.46 Million	125,000 Added 6.53%	2,039,282 $51 Million
Q3 2018 Nov 14, 2018	BUY	$22.66 - $36.8 $43.4 Million - $70.4 Million	1,914,282 New	1,914,282 $54.8 Million

Others Institutions Holding CRNX

# of Institutions

254

Shares Held

89.2M

Call Options Held

26.1K

Put Options Held

11.8K

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.01B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Crinetics Pharmaceuticals, Inc. Transaction History